CD40L treatment or co-culture of CLL B-cells with CD4+ T lymphocytes has been demonstrated to increase CLL B-cell survival, at least partly mediated via IL-4 signaling (267, 268). This evidence concerns the gene IL4 and B-cell chronic lymphocytic leukemia.